Page 91 - Puneet Wadhwa

Biocon rallies 3% as Syngene share sale powers Q4 net

On Thursday, the stock opened at Rs 453 on the BSE and touched a high of Rs 455.5 and a low of Rs 449 till 9:50am

Nomura maintains reduce rating on Hexawre post Q1 earnings

The stock opened at Rs 289 and touched a low of Rs 278.10 on the BSE. As many as 202,568 shares had been traded on the BSE till 10:55am

JSPL tanks 6% as CBI chargesheets chairman Naveen Jindal in coal scam

Another company owned by Jindal, Gagan Sponge, has also been named in the chargesheet

5 stocks account for 50% of nearly 1,800-point Sensex fall

Infosys, Sun Pharma, HDFC, L&T, TCS have collectively contributed 880 points to the Sensex's 1,791-point decline in the past nine days

Infosys Q4FY15 results impact: Stock falls 4%

By comparison, the CNX IT index slipped 1.7% and the benchmark CNX Nifty lost around 1% in trade at 2:45pm

What to expect from Infosys Q4FY15 results on Friday

Here is a compilation of what leading brokerages and research houses expect from Q4FY15 results of Infosys on Friday

Market Watch: 15 stocks to watch in trade on Thursday

Biocon, HDFC Bank, Cairn India, M&M Financial, Clariant Chemicals and Rallis India likely to react to newsflow

Wipro slips 4% post results. Should you dump the stock?

Given the recent results, analysts suggest that the stock will continue to remain under pressure for some time

Sun Pharma slips 9% as Daiichi Sankyo exits. Should you buy?

A combined 276.63 million shares representing 11.5% of total equity of Sun Pharma changed hands on the NSE and BSE

Google, Facebook, Twitter to gain from growth of eCommerce in India: UBS

Maintains sell rating on Just Dial and buy rating on Bharti Airtel, Idea Cellular, Info Edge in a recent report

Investors cash out of FMCG stocks ahead of results

Disturbed by lack of pick-up in consumption, especially rural, and likelihood of lack of good news on corporate earnings

TCS slips over 3% on Q4 earnings; Nomura maintains buy rating

Though the revenues came in as a disappointment, Nomura says, the results were in line with expectations on margins and ahead on PAT

FIIs cut stake in banks in March 2015 quarter

SBI, ICICI Bank, Bank of India and Canara Bank are some of the PSU banks where FIIs have pared stakes

Are markets fully factoring in weak corporate earnings?

A recent report by Motilal Oswal Financial Services, for instance, expects only five sectors to report double-digit PAT growth

Moody's red flags banking sector; cites asset quality concerns

Analysts believe that the concerns highlighted are not new and going ahead, the problems in the banking sector will mend. However, it will be a long drawn process, they say

BSE Small-cap index hits seven-year high; up over 10% in six days

However, investors should consider the company's balance sheet strength and promoter pledging before investing

3 reasons why Moody's has revised India's outlook

Here are three reasons why the Moody's has revised India's outlook

RBI maintains status quo; but what next for the markets?

Don't base investment decision in rate-sensitive stocks solely on its policy. Corporate results remain key: Analysts

International investors are expecting swift results: Paul Donovan

Interview with Global economist & managing director, UBS Investment Bank

Pharma stocks rally; CNX Pharma index up 5%

Thus far in 2015, CNX Pharma and S&P BSE Healthcare indices have surged 26% compared with 5% gain in CNX Nifty and 4.6% rise in the S&P BSE Sensex